Infinity Pharmaceuticals
Heywood Ellenburg has extensive experience in project coordination, particularly in tie point operations. Currently serving as a Tie Point Project Coordinator at IPI since February 2013, Ellenburg is responsible for coordinating client schedules, planning manpower, estimating materials and equipment needs, and overseeing project execution. Previously, as a Tie Point Coordinator at IPI, responsibilities included pricing changes, estimating add-on work, and material ordering. From December 2007 to January 2012, Ellenburg worked as a Piping Planner at Day and Zimmerman, collaborating with client engineers on project design and estimating man-hours. Educational credentials include a certification in Estimating from the American Society of Professional Estimators and an Associate's degree in Welding Technology from Greenville Technical College, along with OSHA 30 training.
This person is not in any offices
Infinity Pharmaceuticals
Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.